KEGG   DRUG: Asenapine maleate
Entry
D02995                      Drug                                   
Name
Asenapine maleate (JAN/USAN);
Saphris (TN)
Product
  Generic
Formula
C17H16ClNO. C4H4O4
Exact mass
401.103
Mol weight
401.8402
Structure
Class
Neuropsychiatric agent
 DG01478  Dopamine antagonist
  DG01474  Dopamine D2-receptor antagonist
Metabolizing enzyme substrate
 DG01892  CYP1A2 substrate
Metabolizing enzyme inhibitor
 DG01645  CYP2D6 inhibitor
Remark
Therapeutic category: 1179
ATC code: N05AH05
Chemical structure group: DG03100
Product (DG03100): D11769<US> D02995<JP/US>
Efficacy
Antipsychotic
  Disease
Schizophrenia [DS:H01649]
Bipolar I disorder [DS:H01653]
Comment
Treatment of psychosis
Target
HTR1A [HSA:3350] [KO:K04153]
HTR2A [HSA:3356] [KO:K04157]
HTR2C [HSA:3358] [KO:K04157]
HTR6 [HSA:3362] [KO:K04162]
HTR7 [HSA:3363] [KO:K04163]
DRD2 [HSA:1813] [KO:K04145]
  Pathway
hsa04080  Neuroactive ligand-receptor interaction
hsa04726  Serotonergic synapse
hsa04728  Dopaminergic synapse
Metabolism
Enzyme: CYP1A2 [HSA:1544]
Interaction
CYP inhibition: CYP2D6 [HSA:1565]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N05 PSYCHOLEPTICS
   N05A ANTIPSYCHOTICS
    N05AH Diazepines, oxazepines, thiazepines and oxepines
     N05AH05 Asenapine
      D02995  Asenapine maleate (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
 Antipsychotics
  2nd Generation/Atypical
   Asenapine
    D02995  Asenapine maleate (JAN/USAN)
 Bipolar Agents
  Bipolar Agents, Other
   Asenapine
    D02995  Asenapine maleate (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  11  Agents affecting central nervous system
   117  Psychotropics
    1179  Others
     D02995  Asenapine maleate (JAN/USAN)
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01478  Dopamine antagonist
   DG01474  Dopamine D2-receptor antagonist
    DG03100  Asenapine
     D02995  Asenapine maleate
 Metabolizing enzyme substrate
  DG01892  CYP1A2 substrate
   DG03100  Asenapine
    D02995  Asenapine maleate
 Metabolizing enzyme inhibitor
  DG01645  CYP2D6 inhibitor
   DG03100  Asenapine
    D02995  Asenapine maleate
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Dopamine
    DRD2
     D02995  Asenapine maleate (JAN/USAN) <JP/US>
   Serotonin
    HTR1A
     D02995  Asenapine maleate (JAN/USAN) <JP/US>
    HTR2A
     D02995  Asenapine maleate (JAN/USAN) <JP/US>
    HTR2C
     D02995  Asenapine maleate (JAN/USAN) <JP/US>
    HTR6
     D02995  Asenapine maleate (JAN/USAN) <JP/US>
    HTR7
     D02995  Asenapine maleate (JAN/USAN) <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D02995
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D02995
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D02995
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D02995
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D02995
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01478  Dopamine antagonist
   DG01474  Dopamine D2-receptor antagonist
    DG03100  Asenapine
 Metabolizing enzyme substrate
  DG01892  CYP1A2 substrate
   DG03100  Asenapine
 Metabolizing enzyme inhibitor
  DG01645  CYP2D6 inhibitor
   DG03100  Asenapine
Other DBs
CAS: 85650-56-2
PubChem: 17397151
ChEBI: 71245
LigandBox: D02995
NIKKAJI: J349.614G
KCF data

ATOM        28
            1   C8y C    13.9474  -15.0494
            2   C1y C    14.8548  -16.0964
            3   C1y C    16.2507  -16.0964
            4   C8y C    17.0882  -14.9797
            5   C8y C    14.2267  -13.6535
            6   C8y C    16.7392  -13.6535
            7   O2x O    15.4829  -13.0254
            8   C8x C    17.7861  -12.6764
            9   C8x C    19.1123  -13.0254
            10  C8x C    19.4612  -14.4213
            11  C8x C    18.4143  -15.3984
            12  C8x C    12.6214  -15.4682
            13  C8y C    11.5744  -14.5608
            14  C8x C    11.8536  -13.1650
            15  C8x C    13.1798  -12.7462
            16  C1x C    16.7392  -17.4224
            17  N1y N    15.6225  -18.2600
            18  C1x C    14.4360  -17.4224
            19  X   Cl   10.2483  -14.9797
            20  C1a C    15.6225  -19.6559
            21  O6a O    21.2759  -16.2359
            22  C6a C    22.6019  -16.2359
            23  O6a O    23.2999  -17.3526
            24  C2b C    23.2999  -15.0494
            25  C2b C    24.9052  -15.0494
            26  C6a C    25.6032  -16.2359
            27  O6a O    26.9990  -16.2359
            28  O6a O    24.9750  -17.4224
BOND        30
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     6   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    4  11 2
            13    1  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17    5  15 2
            18    3  16 1
            19   16  17 1
            20   17  18 1
            21    2  18 1
            22   13  19 1
            23   17  20 1
            24   21  22 1
            25   22  23 2
            26   22  24 1
            27   24  25 2
            28   25  26 1
            29   26  27 2
            30   26  28 1

» Japanese version   » Back

DBGET integrated database retrieval system